Danny Rischin, MD on Phase II Study of Cemiplimab @PeterMacCC

Danny Rischin, MD on Phase II Study of Cemiplimab @PeterMacCC

Cancer-News

1 week
19 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Danny Rischin, MD of Peter MacCallum Cancer Centre @PeterMacCC discusses the phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma.

Read here: https://meetinglibrary.asco.org/record/185846/abstract

Up Next Autoplay